Page last updated: 2024-08-23

captopril and EHS Tumor

captopril has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kazimierczak, U; Kowalczyk, DW; Kwiatkowska, EP; Mackiewicz, A; Suchorska, W; Wysocki, PJ1

Other Studies

1 other study(ies) available for captopril and EHS Tumor

ArticleYear
Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jul-01, Volume: 12, Issue:13

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Sarcoma, Experimental; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2006